Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.
https://www.creative-biolabs.com/
Gesamtlänge aller Episoden: 2 days 18 hours 44 minutes
episode 11: Ep.8 Characterization And Functional Abilities of Regulatory T Cells
This episode focuses on the application of regulatory T cells for the prevention and treatment of graft-versus-host disease.
episode 12: Ep.9 Mechanism of Immunosuppression by Regulatory T Cells
This episode focuses on the regulatory T cell expansion as an attractive option to suppress the development of graft-versus-host disease.
episode 13: Ep.10 Effects of Regulatory T Cells on Tumor Immunity and the Clinical Application
This episode focuses on the mechanisms of immunosuppression by regulatory T cells, including direct and indirect mechanisms.
episode 14: Ep.11 Biology and Function of Natural Killer Cells
This episode focuses on the biology of natural killer (NK) cells and their function for application in tumor therapy.
episode 15: Ep.12 Adoptive NK Cell Therapies
This episode focuses on the approaches and current challenges in using natural killer cells as cancer immunotherapies.
episode 16: Ep.13 Natural Killer Cell Dysfunction in Cancer Therapies
This episode focuses on the understanding of natural killer cell function in healthy humans that has led to translational strategies for the treatment of cancer patients.
episode 17: Ep.14 Human Dendritic Cells
This episode focuses on the in-depth understanding of human dendritic cells and their role in the immune system.
episode 18: Ep.15 Dendritic Cells in Clinical Hematopoietic Cell Transplantation
This episode focuses on the application of human dendritic cells in clinical hematopoietic cell transplantation.
episode 19: Advances in CAR-T Cell Therapy
Various barriers restrict the efficacy and/or prevent the widespread use of CAR-T cell therapies in these patients as well as in those with other diseases, particularly solid tumors. The evolution of CAR designs beyond conventional structures will be...